Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry C Pitot

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|June 10, 2006
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignanciesCynthia Ma, Sumithra J Mandrekar, Steven R Alberts, et al.
Cancer|June 15, 2007
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancerAmanda C Ashley, Daniel J Sargent, Steven R Alberts, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
The International Journal of Biochemistry & Cell Biology|December 25, 2004
Some biochemical and histochemical properties of human liver serine dehydrataseTatsuhiko Kashii, Tomoharu Gomi, Takeshi Oya, et al.
Investigational New Drugs|August 31, 2002
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancerAlex A Adjei, Joel M Reid, Charles Erlichman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumorsAlex A Adjei, Joel M Reid, Robert B Diasio, et al.
Cancer Chemotherapy and Pharmacology|March 9, 2005
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumorsGrace K Dy, Ajit Suri, Joel M Reid, et al.
International Journal of Molecular Sciences|November 4, 2017
Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell CarcinomaKarthik V Giridhar, Carlos P Sosa, David W Hillman, et al.
Biochimica Et Biophysica Acta|April 4, 2006
Enzymatic and biochemical properties of a novel human serine dehydratase isoformHirofumi Ogawa, Tomoharu Gomi, Mikio Nishizawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancerGrace K Dy, James P Thomas, George Wilding, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|June 10, 2006
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignanciesCynthia Ma, Sumithra J Mandrekar, Steven R Alberts, et al.
Cancer|June 15, 2007
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancerAmanda C Ashley, Daniel J Sargent, Steven R Alberts, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
The International Journal of Biochemistry & Cell Biology|December 25, 2004
Some biochemical and histochemical properties of human liver serine dehydrataseTatsuhiko Kashii, Tomoharu Gomi, Takeshi Oya, et al.
Investigational New Drugs|August 31, 2002
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancerAlex A Adjei, Joel M Reid, Charles Erlichman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumorsAlex A Adjei, Joel M Reid, Robert B Diasio, et al.
Cancer Chemotherapy and Pharmacology|March 9, 2005
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumorsGrace K Dy, Ajit Suri, Joel M Reid, et al.
International Journal of Molecular Sciences|November 4, 2017
Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell CarcinomaKarthik V Giridhar, Carlos P Sosa, David W Hillman, et al.
Biochimica Et Biophysica Acta|April 4, 2006
Enzymatic and biochemical properties of a novel human serine dehydratase isoformHirofumi Ogawa, Tomoharu Gomi, Mikio Nishizawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancerGrace K Dy, James P Thomas, George Wilding, et al.
Pageof 9